Abstract:Molecular chaperones play a central role in protein disaggregation. However, the molecular determinants that regulate this process are poorly understood. Hsp104 is an AAA+ ATPase that disassembles stress granules and amyloids in yeast through collaboration with Hsp70 and Hsp40. In vitro studies show that Hsp104 processes different types of protein aggregates by partially translocating or threading polypeptides through the central pore of the hexamer. However, it is unclear how Hsp104 processing influences client protein function in vivo . The middle domain (MD) of Hsp104 regulates ATPase activity and interactions with Hsp70. Here, we tested how MD variants, Hsp104 A503S and Hsp104 A503V , process different protein aggregates. We establish that engineered MD variants fail to resolve stress granules but retain prion fragmentation activity required for prion propagation. Using the Sup35 prion protein, our in vitro and in vivo data indicate that the MD variants can disassemble Sup35 aggregates, but the disaggregated protein has reduced GTPase and translation termination activity. These results suggest that the middle domain can play a role in sensing certain substrates and plays an essential role in ensuring the processed protein is functional. Protein misfolding and assembly can lead to the formation highly ordered aggregates called amyloid. Amyloid is associated with several proteinopathies, including Alzheimer's and Parkinson's disease. Hsp104, the major chaperone disaggregase in yeast, fragments amyloid associated with yeast prions by working in concert with Hsp70 and Hsp40 chaperones to extract monomers from the amyloid in a partial-threading mechanism. Engineered variants within the middle domain (MD) of Hsp104, Hsp104 A503S and Hsp104 A503V , effectively disaggregate and reduce toxicity associated with human aggregating proteins. However, how the middle domain influences protein processing is not clearly defined. Our i n vitro and in vivo data suggest that the MD can help ensure that disaggregated proteins are functional immediately after processing.

Heat Shock Protein 104 (HSP104) Chaperones Soluble Tau Via a Mechanism Distinct from Its Disaggregase Activity.

HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.

Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species

Ratchet-like polypeptide translocation mechanism of the AAA+ disaggregase Hsp104

Heat Shock Proteins Reduce Aggregation and Facilitate Degradation of Tau Protein

The middle domain of Hsp104 can ensure substrates are functional after processing

The molecular chaperone Hsp104—A molecular machine for protein disaggregation

Structural determinants for protein unfolding and translocation by the Hsp104 protein disaggregase

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

Hsp70 exhibits a liquid-liquid phase separation ability and chaperones condensed FUS against amyloid aggregation

Hsp22 with an N-Terminal Domain Truncation Mediates a Reduction in Tau Protein Levels

Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology

Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation

Small heat shock protein 22 kDa can modulate the aggregation and liquid-liquid phase separation behavior of tau

Protein rescue from aggregates by powerful molecular chaperone machines

Human Small Heat Shock Protein B8 Inhibits Protein Aggregation without Affecting the Native Folding Process

HSP110 is a modulator of amyloid beta (Aβ) aggregation and proteotoxicity

Substoichiometric Hsp104 regulates the genesis and persistence of self-replicable amyloid seeds of Sup35 prion domain

Heat Shock Protein 90 in Neurodegenerative Diseases

Synthetic chaperone based on Hsp90-Tau interaction inhibits pathological Tau aggregation and rescues physiological Tau-Microtubule interaction